CYTOSORBENTS CORPORATION - COMMON STOCK

0.9400

02-May-25 16:45:00

15 minutes delayed

Stocks

-0.0700

-6.93%

Today's range

0.8700 - 0.9439

ISIN

N/A

Source

NASDAQ

CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled

20 Apr 2023 07:00:01 By Nasdaq GlobeNewswire
CytoSorbents Announces Board Chairman Al W. Kraus To Retire

19 Apr 2023 07:00:00 By Nasdaq GlobeNewswire
Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation

29 Mar 2023 08:30:00 By Nasdaq GlobeNewswire
CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)

22 Mar 2023 08:09:06 By Nasdaq GlobeNewswire
CytoSorbents Comments on Bank Exposure and Diversified Cash Position

14 Mar 2023 07:00:00 By Nasdaq GlobeNewswire
CytoSorbents Reports Fourth Quarter and Full Year 2022 Results

09 Mar 2023 16:15:00 By Nasdaq GlobeNewswire
New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-Time

07 Mar 2023 07:00:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.